We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

This study has been terminated.
(An interim analysis showed that nitric oxide patches are not enough effective)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00317629
First Posted: April 25, 2006
Last Update Posted: November 24, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Universidad de Antioquia
The University of Akron
Universidad de Santander
Secretaria de Salud de Santander
Secretaria de Salud de Tolima
Information provided by:
Fundación Cardiovascular de Colombia
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)